Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Chris Hyungseop Han picked up the Award of Excellence at the 74th Annual International Magnesium Association (IMA) World Magnesium Conference held in Singapore last month.

Dr. Jan Guy (Immediate Past President, Executive Committee Member, Board of Directors of IMA) (left) Chris Hyungseop Han (right)

The IMA Awards of Excellence program, established in 1962, is an annual program open to all researchers and companies demonstrating outstanding examples of magnesium's use. Nominations are judged by a peer review panel of international experts and winners are recognised worldwide. 

Chris won the award of excellence for his research in the development of Biodegradable Magnesium Alloy for Orthopaedic Applications. 

Often a patient will need two parts of their bones screwed together, which then results in a second operation to have the screws removed. For the past 8 years, Chris has been a part of a research team that overcame these limitations and created a roadmap to the next generation of metallic biodegradable implant materials with completely biocompatible elements. A state of the art method to synchronise the corrosion potential was developed to control the corrosion rate. 

Working closely with major hospitals in Korea, the research team have performed several hundred cases of small bone fixation screws and the results have been promising. The BBC World News ‘Horizons’ programme recently featured the team’s research as a medical breakthrough.

Chris commented:

"I am deeply honoured to have received the award of excellence from IMA. I would like to thank my family, my supervisors (Dr James Edwards and Professor Sion Glyn-Jones), my mentors at Korea Institute of Science and Technology (Dr. Hyun-Kwang Seok and Dr. Yu-Chan Kim) and the U&I Corporation for their support over the years. I am hoping to collaborate with more professionals at Oxford to explore the new possibilities of these biodegradable metallic materials." 

 

clinical Trial Published Clinical Trial Published on PNAS

Similar stories

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

NDORMS researchers awarded grant for study on the effects of COVID-19 vaccines on long COVID

A team of NDORMS researchers including Doctor Annika Jödicke and Doctor Victoria Strauss have been awarded NIHR funding to carry out a study into the effects of different COVID-19 vaccines on long COVID.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.